David Jin

CIK 1930732 · Chief Financial Officer · last filed 2026-06-24

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$29.08M

Companies

4

Total Filings

15

Lifetime Open-Market Net

$36.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
FBIO Chief Financial Officer 1,651,571 $3.39 $5.60M $0 1 2026-06-24
FBIOP Chief Financial Officer 1,251,571 $18.76 $23.48M $36.5K 11 2026-04-01
MBIO Director 286 $0.63 $181 $238 1 2025-12-30
AVENUE THERAPEUTICS, INC. (ATXI) Delisted Interim PFO and COO 65,000 $0.35 $22.9K $0 2 2024-09-25

Recent Filings · Page 2 of 2

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-22 FBIOP Grant (A) +140,000 $0 EDGAR
2023-07-05 AVENUE THERAPEUTICS, INC. (ATXI) Delisted Grant (A) $0 EDGAR
2023-02-14 FBIOP Buy (P) +35,928 $30.0K EDGAR
2022-12-02 FBIOP Buy (P) +5,000 $2.8K EDGAR
2022-10-28 FBIOP Grant (A) +1,350,000 $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.